Predictive value of metabolic syndrome definitions in patients with myocardial infarction with ST segment elevation – are they all the same?

References

• Kassi E, Pervanidou P, Kaltsas G, et al. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48.
   PubMed Web of Science ®Google Scholar
• Kotaro O, Sonal J, Dangas GD. Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am. 2007;91:1169–1184.
   Web of Science ®Google Scholar
• Adamu UG, Umenze IK, Ibok IO, et al. Prevalence of metabolic syndrome according to three defining criteria in hypertensive population in a rural hospital setting. J Hypertens. 2015;4:196.
   Google Scholar
• Kelli HM, Kassas I, Lattouf OM. Cardio metabolic syndrome: a global epidemic. J Diabetes Metab. 2015;6:513.
   Web of Science ®Google Scholar
• Selcuk H, Temizhan A, Selcuk MT, et al. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction. Coron Artery Dis. 2009;20:370–375.
   Web of Science ®Google Scholar
• Takeno M, Yasuda S, Otsuka Y, et al. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: potential association with C-reactive protein. Circ J. 2008;72:415–419.
   PubMed Web of Science ®Google Scholar
• Levantesi G, Macchia A, Marfisi R, GISSI-Prevenzione Investigators, et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol. 2005;46:277–283.
   Web of Science ®Google Scholar
• Won KB, Kim BK, Chang HJ, et al. Metabolic syndrome does not impact long-term survival in patients with acute myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents. Catheter Cardiovasc Interv. 2014;83:713–720.
   Web of Science ®Google Scholar
• Mornar Jelavic M, Babic Z, Pintaric H. Metabolic syndrome: influence on clinical severity and prognosis in patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Acta Cardiol. 2015;70:149–156.
   Web of Science ®Google Scholar
• Van de Werf F, Bax J, Betriu A, ESC Committee for Practice Guidelines (CPG), et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909–2945.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, American Heart Association; National Heart, Lung, and Blood Institute, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circ J. 2005;112:2735–2752.
   Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection. Evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama. 2001;285:2486–2497.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469–480.
   PubMed Web of Science ®Google Scholar
• Cheitlin MD, Armstrong WF, Aurigemma GP, ACC; AHA; ASE. ACC/AHA/ASE 2003 Guideline Update for the clinical application of echocardiography: summary article, et al. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr. 2003; 16:1091–1110.
   PubMed Web of Science ®Google Scholar
• Beltrán-Sánchez H, Harhay MO, Harhay MM, et al. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol. 2013;62:697–703.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Benjamin EJ, Go AS, American Heart Association Statistics Committee; Stroke Statistics Subcommittee, et al. Executive summary: heart disease and stroke statistics—2016 update: A report from the American Heart Association. Circulation. 2016;133:447–454.
   PubMed Web of Science ®Google Scholar
• Roger VL, Go AS, Lloyd-Jones DM, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:188–197.
   PubMed Web of Science ®Google Scholar
• Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis. 2004;173:309–314.
   PubMed Web of Science ®Google Scholar
• Anagnostis P. Metabolic syndrome in the Mediterranean region: Current status. Indian J Endocrinol Metab. 2012;16:72–80.
   PubMedGoogle Scholar
• Solymoss BC, Bourassa MG, Campeau L, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol. 2004;93:159–164.
   PubMed Web of Science ®Google Scholar
• Olijhoek JK, Van der Graaf Y, Banga JD, SMART Study Group, et al. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004;25:342–348.
   PubMed Web of Science ®Google Scholar
• Ford S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2745–2749.
   PubMed Web of Science ®Google Scholar
• Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev. 2008;29:777–822.
   PubMed Web of Science ®Google Scholar
• Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol. 2005;45:1397–1405.
   PubMed Web of Science ®Google Scholar
• De Luca G, Suryapranata H, van’t Hof AWJ, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation. 2004;109:2737–2743.
   PubMed Web of Science ®Google Scholar
• Dohi T, Miyauchi K, Kasai T, et al. Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome. Circ J. 2009;73:1454.
   Web of Science ®Google Scholar
• De Pergola G, Pannacciulli N. Coagulatioin and fibrinolysis abnormalitiesin obesity. J Endocrinol Investig. 2002;25:899–904.
   PubMed Web of Science ®Google Scholar
• Juhan-Vague I, Morange PE, Alessi MC. The insulin resistance syndrome:implications for thrombosis and cardiovascular disease. Pathophysiol Haemos Thromb. 2002;32:269–273.
   Google Scholar
• Marso SP, Mercado N, Maehara A, et al. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes. JACC Cardiovasc Imaging. 2012;5:S42–S52.
   Web of Science ®Google Scholar
• Athyros VG, Ganotakis ES, Tziomalos K, et al. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin. 2010;26:713–719.
   PubMed Web of Science ®Google Scholar
• Milionis HJ, Kostapanos MS, Liberopoulos EN, et al. Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects. Int J Clin Pract. 2007;61:545–551.
   PubMed Web of Science ®Google Scholar
• Anderson JL, Horne BD, Jones HU, Intermountain Heart Collaborative (IHC) Study, et al. Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease. Cardiology. 2004;101:185–193.
   Web of Science ®Google Scholar
• Nigam A, Bourassa MG, Fortier A, et al. The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J. 2006;151:514–521.
   PubMed Web of Science ®Google Scholar
• Zeller M, Steg PG, Ravisy J, Observatoire des Infarctus de Côte-d'Or Survey Working Grou, et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med. 2005;165:1192–1198.
   PubMedGoogle Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and prevention; National Heart, Lung and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar